BIOATLA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.51 USD | -0.33% |
|
-11.70% | -38.62% |
Chart calendar BioAtla, Inc.
f.YG9bX14poi7L37PJyeIIMtAbd4_bmoGppnXGN9lfTaU.DwwIJj1b7WSkp-f-sdVyfLdZQOH22ODb0ViCf51qIO0KJyMyBBH3bJy00A~e328c61d6f62217b4f18ca3f9fd6b8ff
Upcoming events on BioAtla, Inc.
Past events on BioAtla, Inc.
| 2024-05-14 04:30 pm | Q1 2024 Earnings Call |
| 2024-05-14 04:05 pm | Q1 2024 Earnings Release |
| 2024-05-13 09:30 am | Citizens JMP Life Sciences Conference |
| 2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Poster Number: 6340 / 1 |
| 2024-04-08 12:00 pm | American Association for Cancer Research Meeting - Poster Number: 1405 / 3 |
| 2024-04-07 04:30 pm | American Association for Cancer Research Meeting - Poster Number: 744 / 30 |
| 2024-04-07 04:30 pm | American Association for Cancer Research Meeting - Poster Number: 743 / 29 |
| 2024-03-26 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-26 04:01 pm | Q4 2023 Earnings Release |
| 2024-03-08 04:30 pm | American Association for Cancer Research Meeting - Poster Number: 2969 / 16 |
| 2024-01-11 12:45 pm | JPMorgan Healthcare Conference - Fireside Chat |
| 2023-12-13 10:00 am | R&D Day |
| 2023-12-06 01:00 pm | JMP Securities Hematology and Oncology Summit |
| 2023-12-04 11:00 am | Investor Meeting - Key Opinion Leader |
| 2023-11-15 07:00 am | Jefferies London Healthcare Conference |
| 2023-11-07 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-07 04:01 pm | Q3 2023 Earnings Release |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-17 02:30 pm | H.C. Wainwright Immune Cell Engager Conference |
| 2023-08-07 12:00 pm | BTIG Biotechnology Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,20 | 0,43 1,61 -73.32% | 0,25 4,85 -94.85% | 0,00 1,29 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -29,1 -34,7 16.28% | -95,1 -90,7 -4.83% | -107 -110 3.17% | -128 -137 6.06% | -97,4 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -30,1 -34,0 11.45% | -96,4 -96,5 0.09% | -108 -108 0.23% | -130 -137 5.17% | -92,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -35,9 -37,6 4.7% | -95,4 -94,8 -0.65% | -106 -107 0.9% | -123 -131 6.04% | -88,3 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -35,9 -37,6 4.72% | -95,4 -94,8 -0.65% | -106 -108 0.96% | -123 -131 6.04% | -88,3 |
|
EPS USD | Released Forecast Spread | -0,53 | -1,11 -1,25 11.18% | -2,76 -2,80 1.57% | -2,74 -2,87 4.69% | -2,58 -2,76 6.62% | -1,61 |
| Announcement Date | 06/10/20 | 24/03/21 | 28/02/22 | 23/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,30 - | 0,00 0,33 - | 0,00 0,40 - | 0,00 1,29 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -24,0 -25,0 3.87% | -28,8 -23,8 -20.77% | -25,9 -30,8 16.03% | -28,3 -30,5 7.47% | -28,6 -30,0 4.54% | -36,3 -30,0 -21.08% | -34,8 -39,0 10.9% | -24,2 -29,0 16.49% | -25,0 | -26,0 | -22,0 | |||
|
EBIT Million USD | Released Forecast Spread | -24,3 -25,5 4.68% | -29,1 -25,8 -12.4% | -26,2 -30,4 13.95% | -28,6 -28,6 0.28% | -28,9 -30,3 4.62% | -37,2 -31,1 -19.8% | -35,0 -38,6 9.24% | -28,5 -35,2 18.9% | -24,5 -26,2 6.74% | -23,6 | -24,0 | -23,5 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,3 -25,3 4.29% | -28,9 -25,3 -14.28% | -25,8 -30,1 14.26% | -27,5 -28,3 2.64% | -27,5 -30,1 8.67% | -35,8 -30,6 -16.95% | -33,3 -38,2 12.77% | -26,9 -34,5 21.88% | -23,2 -25,3 8.08% | -23,0 | -23,4 | -22,8 | ||
|
Net income Million USD | Released Forecast Spread | -24,3 -25,3 4.29% | -28,9 -25,7 -12.64% | -25,8 -30,0 13.96% | -27,5 -27,4 -0.43% | -27,5 -29,8 7.88% | -35,8 -30,6 -16.95% | -33,3 -38,4 13.18% | -26,9 -34,5 21.88% | -23,2 -25,3 8.08% | -23,0 | -23,4 | -22,8 | ||
|
EPS USD | Released Forecast Spread | -0,65 -0,67 3.09% | -0,77 -0,69 -12.39% | -0,69 -0,80 13.75% | -0,63 -0,73 13.25% | -0,58 -0,64 8.7% | -0,75 -0,64 -17.21% | -0,70 -0,80 12.42% | -0,56 -0,79 29.29% | -0,48 -0,54 11.37% | -0,44 | -0,40 | -0,37 | -0,35 | -0,35 |
| Announcement Date | 04/05/22 | 09/08/22 | 03/11/22 | 23/03/23 | 11/05/23 | 01/08/23 | 07/11/23 | 26/03/24 | 14/05/24 | - | - | - | - | - |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for BioAtla, Inc.
| 2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BCAB Stock
- Calendar BioAtla, Inc.
